Showing results (261-270 of 311) with videos related to
Sort By:
Pageof 32
The Veterinary Record|March 15, 2006
Postmortem diagnosis of preclinical and clinical scrapie in sheep by the detection of disease-associated PrP in their rectal mucosaL González, M P Dagleish, S J Bellworthy, et al.Emerging Infectious Diseases|May 3, 2011
Experimental oral transmission of atypical scrapie to sheepMarion M Simmons, S Jo Moore, Timm Konold, et al.Plos One|May 19, 2011
Detection and localisation of PrP(Sc) in the liver of sheep infected with scrapie and bovine spongiform encephalopathySally J Everest, Andrew M Ramsay, Melanie J Chaplin, et al.Medchemcomm|June 18, 2013
An Amino-Benzosuberene Analogue That Inhibits Tubulin Assembly and Demonstrates Remarkable CytotoxicityRajendra P Tanpure, Clinton S George, Madhavi Sriram, et al.Journal of Medicinal Chemistry|May 7, 2019
Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin PolymerizationHaichan Niu, Tracy E Strecker, Jeni L Gerberich, et al.BMC Veterinary Research|May 1, 2008
Pruritus is a common feature in sheep infected with the BSE agentTimm Konold, Gemma Bone, Alberto Vidal-Diez, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancerM Zweifel, G C Jayson, N S Reed, et al.Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|June 11, 2005
Experimental transmission of chronic wasting disease agent from mule deer to cattle by the intracerebral routeAmir N Hamir, Robert A Kunkle, Randall C Cutlip, et al.Bioorganic & Medicinal Chemistry Letters|December 24, 2016
Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxiaBlake A Winn, Zhe Shi, Graham J Carlson, et al.British Journal of Cancer|April 15, 2010
A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancerG J Rustin, G Shreeves, P D Nathan, et al.Pageof 32